Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential 6-Thioguanine After Methotrexate in LCH
NCT00588536Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 1995
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tioguanine, methotrexate in Langerhans cell histiocytosis (LCH), sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 1995; status: completed.
02
Drugs
tioguaninemethotrexate
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT00588536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588536.